microalbuminuria

From Aaushi
Jump to navigation Jump to search

Etiology

Laboratory

* urine albumin & urine creatinine in same units

Clinical significance

Factors favoring resolution of microalbuminuria in diabetics[2]*

* ACE inhibitors but not ARBs, associated with resolution of microalbuminuria in type-2 diabetes[5]

* ACE inhibitors are NOT associated with resolution of microalbuminuria in type-1 diabetes[2]

* olmesartan (an ARB) may delay or prevent microalbuminuria in patients with type-2 diabetes at the cost of increased cardiovascular risk[6]

* ACE inhibitors or ARBs do not prevent of slow progression of diabetic nephropathy in normotensive diabetics with microalbuminuria

More general terms

Additional terms

References

  1. 1.0 1.1 1.2 1.3 Medical Knowledge Self Assessment Program (MKSAP) 11, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2012, 2015, 2018, 2021.
  2. 2.0 2.1 2.2 Journal Watch 23(13):107, 2003 Perkins BA et al Regression of microalbuminuria in type 1 diabetes. NEJM 348(23):2285, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12788992
  3. 3.0 3.1 Journal Watch 25(11):90, 2005 Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D'Agostino RB, Levy D, Vasan RS. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation. 2005 Mar 22;111(11):1370-6. Epub 2005 Feb 28. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15738353
  4. 4.0 4.1 Mahmoodi BK et al Microalbuminuria and the risk of venous thromboembolism. JAMA 2009 May 6; 301:1790. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19417196
  5. 5.0 5.1 Mann JFE et al Effect of telmisartan on renal outcomes: A randomized trial. Ann Intern Med 2009 Jul 7; 151:1 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19451556
    Bilous R et al. Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: Three randomized trials. Ann Intern Med 2009 Jul 7; 151:11. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19451554
    Parfrey PS Angiotensin-receptor blockers in the prevention or treatment of microalbuminuria. Ann Intern Med 2009 Jul 7; 151:63. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19581647
  6. 6.0 6.1 Haller H et al Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes N Engl J Med 2011; 364:907-917March 10, 2011 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21388309 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1007994
  7. Prescriber's Letter 19(4): 2012 COMMENTARY: Treating Microalbuminuria CHART: Antihypertensive Combinations Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=280425&pb=PRL (subscription needed) http://www.prescribersletter.com
  8. Hallan SI et al Age and Association of Kidney Measures With Mortality and End-stage Renal Disease JAMA. Oct 30, 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23111824 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1387683
    de Boer IH Chronic Kidney Disease--A Challenge for All Ages JAMA. Oct 30, 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23111858 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1387684

Patient information

microalbuminuria patient information